The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.
- DOI
- 10.3389/fphar.2026.1939700
- Published
- 2026
- Container
- Frontiers in pharmacology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1939700,
title = {The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.},
author = {Bruno L and Di Berardino M and Cafaro G and Pozzolo RD and Ceccarelli F and Shoenfeld Y and Gerli R and Bartoloni E and Perricone C},
year = {2026},
journal = {Frontiers in pharmacology},
doi = {10.3389/fphar.2026.1939700},
url = {https://doi.org/10.3389/fphar.2026.1939700}
}RIS
TY - JOUR TI - The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes. AU - Bruno L AU - Di Berardino M AU - Cafaro G AU - Pozzolo RD AU - Ceccarelli F AU - Shoenfeld Y AU - Gerli R AU - Bartoloni E AU - Perricone C PY - 2026 JO - Frontiers in pharmacology DO - 10.3389/fphar.2026.1939700 UR - https://doi.org/10.3389/fphar.2026.1939700 ER -
APA
L, B., M, D. B., G, C., RD, P., F, C., Y, S., R, G., E, B., & C, P. (2026). The role of the JAK/STAT pathway in the pathogenesis and treatment of post-COVID autoimmune syndromes.. Frontiers in pharmacology. https://doi.org/10.3389/fphar.2026.1939700
Source records
- pubmed · retrieved 2026-11-10T19:04:32.836Z